Moderna
MRNA
#1188
Rank
NZ$26.80 B
Marketcap
$69.67
Share price
-0.43%
Change (1 day)
-53.78%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of September 2024 : NZ$12.14 Billion

According to Moderna 's latest financial reports the company has NZ$12.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$13.60 B-12.76%
2022-12-31NZ$15.59 B-0.69%
2021-12-31NZ$15.70 B145.91%
2020-12-31NZ$6.38 B289.94%
2019-12-31NZ$1.63 B-27.79%
2018-12-31NZ$2.26 B113.07%
2017-12-31NZ$1.06 B-30.31%
2016-12-31NZ$1.52 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.15 B-98.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.81 B 112.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.8 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.91 B-59.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.79 B 104.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$1.20 B-90.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.89 B 195.57%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA